Pharmaceuticals in Australia

May 2020 | 45 pages | ID: P395686B0E6EN
MarketLine

Abstracts

Pharmaceuticals in Australia

SUMMARY

Pharmaceuticals in Australia industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2015-19, and forecast to 2024). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

KEY HIGHLIGHTS

• The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
• The Australian pharmaceuticals market had total revenues of $12,080.0m in 2019, representing a compound annual growth rate (CAGR) of 7% between 2015 and 2019.
• Australian healthcare is based on the Australian Pharmaceutical benefit scheme, which enables patients to buy a wide range of prescription drugs at a subsidized price. This has been expanded in recent years to include more medicines.
• The Australian pharmaceutical market has been in recovery since the decline posted in 2017 and the focus of the Australian government in the past three years has been on pricing reform.

SCOPE

• Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in Australia
• Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Australia
• Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
• Add weight to presentations and pitches by understanding the future growth prospects of the Australia pharmaceuticals market with five year forecasts

REASONS TO BUY

• What was the size of the Australia pharmaceuticals market by value in 2019?
• What will be the size of the Australia pharmaceuticals market in 2024?
• What factors are affecting the strength of competition in the Australia pharmaceuticals market?
• How has the market performed over the last five years?
• Who are the top competitiors in Australia's pharmaceuticals market?

Contents

1 EXECUTIVE SUMMARY

1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market share
1.5. Market rivalry
1.6. Competitive Landscape

2 MARKET OVERVIEW

2.1. Market definition
2.2. Market analysis

3 MARKET DATA

3.1. Market value

4 MARKET SEGMENTATION

4.1. Geography segmentation

5 MARKET OUTLOOK

5.1. Market value forecast

6 FIVE FORCES ANALYSIS

6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry

7 COMPETITIVE LANDSCAPE

7.1. Market share
7.2. Who are the leading players?
7.3. What are the strengths/weaknesses of leading players?
7.4. What strategies do leading players follow?
7.5. What impact is COVID-19 having on the market?

8 COMPANY PROFILES

8.1. Pfizer Inc.
8.2. Aspen Pharmacare Holdings Ltd
8.3. AstraZeneca AB
8.4. GlaxoSmithKline Plc

9 MACROECONOMIC INDICATORS

9.1. Country data

10 APPENDIX

10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine

List Of Tables

LIST OF TABLES

Table 1: Australia pharmaceuticals market value: $ billion, 2015-19
Table 2: Australia pharmaceuticals market geography segmentation: $ billion, 2019
Table 3: Australia pharmaceuticals market value forecast: $ billion, 2019-24
Table 4: Australia pharmaceuticals market share: % share, by value, 2019
Table 5: Pfizer Inc.: key facts
Table 6: Pfizer Inc.: Annual Financial Ratios
Table 7: Pfizer Inc.: Key Employees
Table 8: Pfizer Inc.: Key Employees Continued
Table 9: Aspen Pharmacare Holdings Ltd: key facts
Table 10: Aspen Pharmacare Holdings Ltd: Annual Financial Ratios
Table 11: Aspen Pharmacare Holdings Ltd: Key Employees
Table 12: AstraZeneca AB: key facts
Table 13: AstraZeneca AB: Key Employees
Table 14: GlaxoSmithKline Plc: key facts
Table 15: GlaxoSmithKline Plc: Annual Financial Ratios
Table 16: GlaxoSmithKline Plc: Annual Financial Ratios (Continued)
Table 17: GlaxoSmithKline Plc: Key Employees
Table 18: GlaxoSmithKline Plc: Key Employees Continued
Table 19: Australia size of population (million), 2015-19
Table 20: Australia gdp (constant 2005 prices, $ billion), 2015-19
Table 21: Australia gdp (current prices, $ billion), 2015-19
Table 22: Australia inflation, 2015-19
Table 23: Australia consumer price index (absolute), 2015-19
Table 24: Australia exchange rate, 2015-19

List Of Figures

LIST OF FIGURES

Figure 1: Australia pharmaceuticals market value: $ billion, 2015-19
Figure 2: Australia pharmaceuticals market geography segmentation: % share, by value, 2019
Figure 3: Australia pharmaceuticals market value forecast: $ billion, 2019-24
Figure 4: Forces driving competition in the pharmaceuticals market in Australia, 2019
Figure 5: Drivers of buyer power in the pharmaceuticals market in Australia, 2019
Figure 6: Drivers of supplier power in the pharmaceuticals market in Australia, 2019
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Australia, 2019
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in Australia, 2019
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in Australia, 2019
Figure 10: Australia pharmaceuticals market share: % share, by value, 2019